Bayesian Capital Management’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,800
Closed -$256K 608
2025
Q2
$256K Buy
+1,800
New +$255K 0.04% 414
2024
Q4
Sell
-4,327
Closed -$709K 761
2024
Q3
$709K Buy
+4,327
New +$639K 0.08% 301
2024
Q2
Sell
-15,189
Closed -$2.1M 832
2024
Q1
$2.1M Sell
15,189
-900
-6% -$108K 0.2% 144
2023
Q4
$1.69M Hold
16,089
0.18% 151
2023
Q3
$1.52M Buy
16,089
+5,700
+55% +$581K 0.17% 150
2023
Q2
$1.04M Buy
+10,389
New +$964K 0.11% 246
2022
Q2
Sell
-5,287
Closed -$598K 851
2022
Q1
$598K Buy
+5,287
New +$594K 0.09% 334
2020
Q4
Sell
-5,209
Closed -$446K 510
2020
Q3
$446K Sell
5,209
-3,457
-40% -$295K 0.11% 250
2020
Q2
$686K Sell
8,666
-9,300
-52% -$726K 0.15% 194
2020
Q1
$1.37M Buy
17,966
+4,266
+31% +$335K 0.3% 75
2019
Q4
$1.03M Buy
+13,700
New +$909K 0.18% 171
2017
Q2
Sell
-8,200
Closed -$557K 473
2017
Q1
$557K Buy
+8,200
New +$543K 0.26% 141

Other funds holding DVA

Bayesian Capital Management's DVA Position: Q3 2025 in Review

Bayesian Capital Management sold out of DaVita (DVA) in Q3 2025, closing a stake of 1,800 shares — an estimated $256K sold.

Bayesian Capital Management first reported a position in DVA in Q1 2017 and held it in 12 quarters. The position peaked at $2.1M in Q1 2024. 562 funds tracked by Wall St. Rank hold DVA as of Q3 2025.

  • Bayesian Capital Management reported no remaining DaVita position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 1,800 DaVita shares in Q3 2025, an estimated $256K.
  • Bayesian Capital Management first reported a position in DaVita in Q1 2017 and held it in 12 quarters.
  • Bayesian Capital Management's DaVita position peaked at $2.1M in Q1 2024.
  • 562 funds tracked by Wall St. Rank held DaVita as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.